STEPHANE POSTIC

About STEPHANE POSTIC

Stéphane Postic is currently Chief Financial Officer (CFO) at Medincell, a listed biopharmaceutical company focused on long-acting injectable treatments. He joined the group with a strong reputation as a finance executive experienced in supporting innovative, high-growth companies. His profile is closely associated with financial structuring, growth management, and the governance discipline required in a biotechnology company moving through industrial and commercial acceleration. At Medincell, he is part of the leadership team supporting the international expansion of the BEPO® technology platform, partnerships with major pharmaceutical companies, and the company’s path toward operating profitability. A graduate of EM Lyon, Stéphane Postic brings more than 25 years of experience in finance, including around 20 years working alongside growth-stage companies. Over time, he has developed recognized expertise in corporate finance, strategic planning, investor relations, and financial governance. This background is particularly valuable in a listed-company environment, where transparency, precision in financial management, and credibility with capital markets are essential. At Medincell, he is involved in core strategic matters such as funding optimization, value-creation analysis, growth-stage planning, and the support of key commercialization milestones. The company’s financial communications have highlighted his role in shaping Medincell’s financial trajectory, including the objective of reaching operating profitability in the coming years. His position within Medincell’s Leadership Team confirms his influence on day-to-day governance and on decisions with a direct impact on performance and organizational resilience. More broadly, Stéphane Postic represents a finance leader profile centered on execution, rigor, and value creation in a demanding sector where science, industrial partnerships, and capital management must advance together.